ELISA-based measurement of plasma total Aβ1-40 and Aβ1-42, and CSF total and free Aβ1-40 and Aβ1-42 in the presence of solanezumab, a mid-domain anti-A beta antibody

Alzheimer's & Dementia: The Journal of the Alzheimer's Association(2009)

引用 1|浏览17
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要